CLINICAL_TRIALS
trial_result
· 2026-03-31
Clinical Trial Update: A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD) [Phase 1]
Summary
Phase 1b open-label study of DISC-3405 in participants with Sickle cell disease is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Disc Medicine, Inc | Conditions: Sickle Cell Disease | Phase 1 | Status: RECRUITING